Caroline Diaz
Consigliere Generale presso DOVA PHARMACEUTICALS, INC.
Posizioni attive di Caroline Diaz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Consigliere Generale | - | - |
| VERONA PHARMA PLC | Consigliere Generale | 01/10/2021 | - |
Storia della carriera di Caroline Diaz
Precedenti posizioni note di Caroline Diaz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Consigliere Generale | - | - |
Formazione di Caroline Diaz
| Hope College | Undergraduate Degree |
| University of North Carolina at Chapel Hill | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 3 |
Posizioni
| General Counsel | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Caroline Diaz
- Esperienza
